Rapport Therapeutics’ $150 Million Series B Funding Round

Goodwin advised Rapport Therapeutics on the fundraising.Rapport Therapeutics announced the completion of its $150 million in Series B funding. Led by Cormorant Asset Management, the round…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Pietro Martinoia

This content is for Standard 1 Year members only.
Login Join Now